Clinical Trials Browser

OTHER × Multiple Myeloma × pidilizumab × Clear all

NCT01067287 2025-01-24

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Phase 2 Active not recruiting

Multiple Myeloma

NCT02077959 2023-01-27

Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma